Litigation News

Natco Pharma faces ongoing patent litigation with Novo Nordisk over Semaglutide rights that could impede market access for its CDSCO-approved generic version launching March 2026. Patent revocation suits against Novo Nordisk's patent rights create uncertainty, as adverse rulings would significantly limit Natco's ability to capitalize on the diabetes drug market opportunity. Competitors like Dr. Reddy's and Sun Pharma have already secured judicial permissions for exports, highlighting the litigation's impact on market positioning.

PTAB issued precedential decision in Realtek Semiconductor Corp. v. ParkerVision, Inc. denying Realtek's time-barred copycat petition seeking joinder with pending Texas Instruments/NXP IPR proceedings challenging ParkerVision patent. PTAB established that time-barred parties may join pending proceedings "only in exceptional circumstances," concluding fairness and discretion weighed against allowing Realtek to proceed despite statutory permission for time-barred joinder petitions under § 315(c).

Federal Circuit ruled US Patent No. 7,679,637 LLC's web conferencing patent invalid under 35 U.S.C. § 101 in case against Google LLC. Court found claims directed to abstract idea of asynchronous web conference review using purely functional language without technical improvement. Patent failed Alice test steps one and two, merely applying known time-shifting functions to conventional systems. Decision contrasted with GoPro case where concrete technological improvements supported patent eligibility.

FairLight Innovations LLC, managed by Korean patent monetization firm Ideahub Inc., sued TCL in Eastern District of Texas alleging infringement of five LED fabrication patents targeting displays and TVs with LED, QLED, and QD-MINI LED technologies. Patents acquired from Seoul Semiconductor, Chang Gung University, and Suzhou Lekin Semiconductor. FairLight claims willful infringement, citing March 2021 notice letter. McKool Smith represents plaintiff. Case assigned to Judge Schroeder. Ideahub operates three active US litigation campaigns.

Lone Star Document Management revived its patent campaign in West Texas federal court, filing six new cases against Atlassian, Document Logistix, Dropbox, HCL Technologies, IBM, and Oracle. The suits assert patent 6,918,082 covering document review with metadata, targeting defendants' document management platforms. The patent, invented by Jeffrey Gross and Matthew Parker, previously generated litigation from 2008-2017 before going dormant. Gross operates numerous NPE litigation campaigns. Devlin Law Firm represents the plaintiff.

General Motors filed a patent infringement lawsuit against aftermarket parts suppliers to protect key vehicle components. The lawsuit escalates GM's efforts to control aftermarket revenue and intellectual property enforcement. Concurrent changes to US climate regulations removing federal greenhouse gas standards and mandatory EV requirements may influence GM's capital allocation between electric and internal combustion models, potentially affecting the company's litigation strategy and product planning approach.

Nokia won patent lawsuit against Acer and Asus at Munich I Regional Court over H.265 video codec patent EP2375749. Court ruled manufacturers were "unwilling to license" despite Nokia's FRAND-compliant offers. Sales ban now enforced in Germany - Acer's website offline, Asus PCs marked "out of stock." Nokia deposited millions for provisional enforcement. Both manufacturers considering appeals. Retailers can sell existing inventory but receive no replenishment until resolution.

Nokia obtained German court ruling against Acer and ASUS for violating HEVC video codec patents. Both PC manufacturers must suspend sales in Germany until obtaining proper Nokia licensing. Third-party retailers can sell existing inventory but cannot import new stock. Hisense faced similar situation and purchased license earlier this month. Companies may be experiencing technical licensing issues or questioning cost-effectiveness for single market.

Novo Nordisk sued Hims & Hers for patent infringement over compounded semaglutide, forcing the company to cancel its Wegovy alternative weight-loss product. The lawsuit, combined with FDA action against Hims' $49 compounded weight-loss pill citing quality and safety violations, triggered a 48% stock selloff. The HHS matter has been referred to the Department of Justice. Management hopes to resolve the Novo Nordisk dispute through partnership to offer branded GLP-1 products.

AstraZeneca won a Federal Court injunction blocking Pharmacor from listing generic versions of diabetes drug Forxiga on Australia's Pharmaceutical Benefits Scheme. Justice Kylie Downes restrained Pharmacor from selling two dapagliflozin products after AstraZeneca sued for patent infringement in December. While Pharmacor admits infringement but claims the patent is invalid, the judge found AstraZeneca's case strong and granted the injunction to preserve its monopoly until the patent expires October 2027. Trial scheduled for August.